Study finds tuberculosis changes liver metabolism and could promote diabetes
Mycobacterium tuberculosis alters the immunometabolic landscape of the liver. Credit: PLOS Pathogens (2024). DOI: 10.1371/journal.ppat.1012565

Scientists from the University of Leicester have discovered that tuberculosis disrupts glucose metabolism in the body.

The findings, which have now been published in PLoS Pathogens, complement the understanding that diabetes worsens the symptoms of tuberculosis. Importantly, they now say, undiagnosed tuberculosis could be pushing vulnerable patients towards metabolic disease such as diabetes.

Tuberculosis (TB) is a bacterial infection which spreads by inhaling tiny droplets from the lungs of an infected person. It can affect any part of the body but mainly affects the lungs and remains one of the most devastating infectious diseases worldwide, killing over 4,000 people every day.

Prevention through the development of improved vaccines remains a priority for the World Health Organization. Currently, only one vaccine exists for TB and this is predominantly given to infants and young children to help protect them from severe forms of infection.

Scientists at the University are researching tuberculosis in the hope of creating improved vaccines and are specifically looking at ways in which undiagnosed and subclinical infection can impact health. This new discovery, they say, could pave the way to define the molecular pathways by which the immune response changes liver metabolism, thereby allowing for the creation of targeted interventions.

Professor Andrea Cooper from the University’s Leicester Tuberculosis Research Group (LTBRG), is among the authors on the paper. She said, “Our paper changes the focus from diabetes making TB worse to the possibility that late diagnosis of TB can contribute to disruption of glucose metabolism, insulin resistance and therefore can promote progress towards diabetes in those that are susceptible.

“As diabetes compromises drug treatment, our paper also supports the idea that metabolic screening should be involved in any drug or vaccine trials.”

The study first used laboratory models of pulmonary TB to examine the changes happening within the liver during the early stages of infection. It found that an immune response was triggered within the liver cells and glucose metabolism was altered.

The primary author Dr. Mrinal Das then reanalyzed published metabolic data from humans, where he found that liver glucose metabolism was also disrupted when people progressed to TB from latent infection.

Professor Cooper added, “Our future aim is to define the molecular pathways by which the immune response is changing liver metabolism, allowing us to potentially create targeted interventions. We will also be investigating how latent TB (which is infection with the bacterial agent of TB without significant symptoms) might be impacting metabolic health in humans.”

More information:
Mrinal K. Das et al, Altered hepatic metabolic landscape and insulin sensitivity in response to pulmonary tuberculosis, PLOS Pathogens (2024). DOI: 10.1371/journal.ppat.1012565

Citation:
Study finds tuberculosis changes liver metabolism and could promote diabetes (2024, October 21)
retrieved 23 October 2024
from https://medicalxpress.com/news/2024-10-tuberculosis-liver-metabolism-diabetes.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Before you post, please prove you are sentient.

what is 2 plus 7?

Explore More

Bacterial infections could be trigger for type 1 diabetes, new research suggests

Graphical abstract. Credit: Journal of Clinical Investigation (2024). DOI: 10.1172/JCI164535 For the first time, scientists have found that proteins from bacteria can trigger the immune system to attack insulin-producing cells,

Long-term benefits of weight-loss surgery in young people

Young people with severe obesity who underwent weight-loss surgery at age 19 or younger continued to see sustained weight loss and resolution of common obesity-related comorbidities 10 years later, according

New system offers more reliable, cost-effective solution for continuous glucose monitoring

An insertable glucose sensor using a compact and cost-effective phosphorescence lifetime imager and machine learning. Credit: UCLA Engineering Institute for Technology Advancement A team of researchers from the University of